StockClub

MGRX

MGRXMangoceuticals, Inc.$ --
Mangoceuticals, Inc.

Mangoceuticals, Inc.

MGRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY -36.8%
Operating Income
-8M USD
YoY -329.1%
Net Income
-8M USD
YoY -281.1%
EPS
-0.69$
YoY +30.5%

Revenue

$361,661
FY2023 Q4$731,493
$731,493
Q4
FY2024 Q1$214,095
$214,095
Q1
FY2024 Q2$377,258
$377,258
Q2
FY2024 Q3$510,626
$510,626
Q3
FY2024 Q4$615,873
$615,873
Q4
FY2025 Q1$109,306
$109,306
Q1
FY2025 Q2$277,415
$277,415
Q2
FY2025 Q3$361,661
$361,661
Q3
Actual
$-148,965 (-29.2%)

Net Income

$-17.9M
FY2023 Q4$-9.2M
$-9.2M
Q4
FY2024 Q1$-2.4M
$-2.4M
Q1
FY2024 Q2$-4.8M
$-4.8M
Q2
FY2024 Q3$-6.8M
$-6.8M
Q3
FY2024 Q4$-8.7M
$-8.7M
Q4
FY2025 Q1$-4.8M
$-4.8M
Q1
FY2025 Q2$-10.3M
$-10.3M
Q2
FY2025 Q3$-17.9M
$-17.9M
Q3
Actual
$-11.1M (-164.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$8,939
FY2022
$8,939
FY2023BEAT
Actual:$731,493
Est:$17,878
FY2023BEAT
$731,493
FY2024
Actual:$615,873
FY2024
$615,873

Analyst Estimates

No forecast data